latory roles. A mutation (F142L) affecting only one of the six CALM alleles is associated with long QT syndrome (LQTS) characterized by recurrent cardiac arrests. This phenotypic severity is unexpected from the predicted allelic balance. In this work, the effects of heterozygous CALM1-F142L have been investigated in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) obtained from a LQTS patient carrying the F142L mutation, i.e. in the context of native allelic ratio and potential gene modifiers. 
Methods and Results
Skin fibroblasts of the mutation carrier and two unrelated healthy subjects (controls) were reprogrammed to hiPSC and differentiated into hiPSC-CMs. Scanty I K1 expression, an hiPSC-CMs feature potentially biasing repolarization, was corrected by addition of simulated I K1 (Dynamic-Clamp). Abnormalities in repolarization ratedependency (in single cells and cell aggregates), membrane currents and intracellular Ca 2þ dynamics were evaluated as putative arrhythmogenic factors. CALM1-F142L prolonged repolarization, altered its rate-dependency and its response to isoproterenol. This was associated with severe impairment of Ca 2þ -dependent inactivation (CDI) of I CaL , resulting in augmented inward current during the plateau phase. As a result, the repolarization of mutant cells failed to adapt to high pacing rates, a finding well reproduced by using a recent hiPSC-CM action potential model. The mutation failed to affect I Ks and I NaL and changed I f only marginally. Intracellular Ca 2þ dynamics and Ca 2þ store stability were not significantly modified. Mutation-induced repolarization abnormalities were reversed by verapamil. 
.. Conclusion
The main functional derangement in CALM1-F142L was prolonged repolarization with altered rate-dependency and sensitivity to b-adrenergic stimulation. Impaired CDI of I CaL underlined the electrical abnormality, which was
Introduction
The congenital long QT syndrome (LQTS) is a genetic disorder characterized by QT interval prolongation and by propensity to life-threatening arrhythmias. 1 We recently provided the first evidence of a malignant form of LQTS associated with calmodulin (CaM) mutations 2 ; other reports of CaM mutations in arrhythmogenic syndromes have followed. [3] [4] [5] CaM is a small Ca 2þ -binding protein essential for multiple signalling processes in eukaryotic cells. 6 Mammals have three CaM genes (CALM1, 2, and 3) that encode identical amino acid sequences. 7 In the heart, CaM 3, 9, 10 In the setting of LQTS, heterologous expression of mutated CALM is associated with delayed I CaL inactivation, prolonged repolarization and perturbed intracellular Ca 2þ handling. 11, 12 However, heterologous expression of mutant constructs cannot reproduce the amount and subcellular localization of the abnormal protein. Therefore, albeit unveiling mutation effects potentially involved in arrhythmogenesis, previous studies did not clarify whether these effects are truly present in mutation carriers and to which extent they may contribute to electrical instability. The present study evaluates the effects of an heterozygous CALM1-F142L mutation with reduced Ca 2þ affinity, first identified in a LQTS patient suffering multiple cardiac arrests since infancy, 2 using 'induced pluripotent stem cell-derived cardiomyocytes' (hiPSC-CMs) generated from patient's skin fibroblasts. This allowed to test mutation effects in the context of the patient's own genotype, including potential adaptive transcriptional or post-transcriptional remodelling. The results demonstrate that defective I CaL inactivation is the dominant mutation consequence and suggest the resulting repolarization delay as the most likely arrhythmogenic effect.
Methods
The Ethical Committee of the Fondazione IRCCS Policlinico San Matteo approved the study, which was performed in accordance with the Declaration of Helsinki. All samples were collected after obtaining informed consent from the donors. The investigation conforms to the Guide of the Care and Use of Laboratory Animals (NIH publication No. 85-23, revised 2011) and to the guidelines for animal care endorsed by Universit a Milano-Bicocca. An expanded Methods section is available in the Supplementary material online.
Generation and differentiation of induced pluripotent stem cells
Human induced pluripotent stem cells (hiPSCs) were generated by Sendai virus-mediated reprogramming of dermal fibroblasts and differentiated into cardiac bodies (CB) 13 (see Supplementary material online, Figures S1 and S2 for details). For patch-clamp measurements, mature CBs were dissociated into single hiPSC-CMs and analysed within 3-5 days. The presence of the CALM1-F142L mutation was verified by PCR on skin fibroblasts, hiPSCs and hiPSC-CMs (see Supplementary material online, Figure S1 , primer sequences in Table S1 ).
Molecular studies
Gene expression was quantified by qRT-PCR, the results were normalized to GAPDH. Total CaM protein level was quantified by densitometric analysis of western blots. CaMKII activity was measured in hiPSC-CMs by a FRET assay based on the biosensor Camui-CR 14 cloned into a lentiviral vector.
Electrical activity in multicellular preparations and single cells
Extracellular field-potentials were recorded at 37 C in spontaneously beating CBs by Multiple Electrode Array (MEA). Field-potential duration, reflecting electrical systole, was measured from the onset of the sharp positive deflection to the peak of the secondary slow deflection 15 ; for simplicity, we will refer to this measurement as QT, which was ratecorrected (QTc) by Bazett's formula. CBs contraction was recorded with a Video Edge detection System. Action potentials (APs) were recorded by whole-cell patch-clamp in hiPSC-CM paced at 0.5, 1, 2, and 3.3 Hz during Tyrode superfusion (36.5 C) . Under native conditions, hiPSC-CM had partially depolarized diastolic potentials (E diast -50.5 ± 3.7 mV at 0.5 Hz), a likely consequence of low I K1 expression in immature myocytes. 16 Thus, numerically modelled I K1 17 (see Supplementary material online, The 'gain' of the coupling between membrane excitation and Ca 2þ release was calculated as the ratio between CaT amplitude (F/F 0 )
and Ca 2þ influx, obtained by integrating I CaL up to the time of CaT peak.
The composition of experimental solutions is reported in the Supplementary material online.
Numerical simulations
Results of current clamp experiments were simulated in silico using a recently published hiPSC-CM AP model. 21 The I CaL kinetic, as characterized in hiPSC-CMs in CTR1 and F142L was included into the model (see Supplementary material online). An additional amount of I K1 , based on the O'Hara-Rudy model of adult myocyte, 17 was incorporated in both CTR and F142L to mimic DC experimental conditions.
Statistics
Student's t-test or ANOVA for paired or unpaired measurements were applied as appropriate, with Bonferroni's correction in post-hoc comparisons. v 2 statistics was used for comparison of categorical variables (GraphPad Prism 5). Data are expressed as mean ± SE; P < 0.05 defines significance, sample size is reported in figure legends.
Results

Characteristics of hiPSC-CMs donors
The proband under study is a young boy who suffered multiple syncopal events and cardiac arrest at the age of 14 years old. His QTc was very prolonged (between 600 and 700 ms) with episodes of T wave alternans often recorded by ECG Holter monitoring. When he was 9, mean HR was 66 b/min during the day, but at night HR dramatically dropped to less than 40 b/min. As compared with that of a normal subject, his QT/ RR relationship was strongly non-linear, becoming significantly steeper at short RR intervals (see Supplementary material online, Figure S3 and Table S3 ). Family history is unknown since he was adopted. Two mutant hiPSC-CMs clones (c1 and c2) were obtained from patient's biopsy. Data from c1 and c2 are reported separately for I CaL characterization ( Figure 2 ) and, being closely comparable, have been pooled for the remaining studies. Because proband's relatives were unavailable, we used as healthy controls two genetically unrelated subjects: a 32-year-old Caucasian female (CTR1) and a 27-year-old Afro-American male (CTR2). For I CaL characterization mutant hiPSC-CMs were compared to those of both CTR1 and CTR2; in the remaining studies CTR1 was used as control.
Molecular characterization of hiPSC-CMs demonstrated cardiomyocytelike patterns of mRNA and protein expression (Figure 1 ), as also detailed in the Supplementary material online.
Transcriptional effects
To test for transcriptional changes secondary to the mutation, gene expression of CaM isoforms, ion channels, Ca 2þ handling proteins and other Ca 2þ binding proteins was analysed in CTR1 and mutant hiPSCCMs. As shown in Figure 1 , the mutation did not affect the expression of any of these genes ( Figure 1 ). Also the levels of total CaM protein were Figure S4 ).
Effects on I CaL properties
We analysed I CaL properties in c1 and c2 mutant hiPSC-CMs clones and in CTR1 hiPSC-CMs. In both mutant clones peak I CaL density ( Figure 2A ) was similar to that of CTR1, but the sustained I CaL component was significantly larger. In both mutant clones inactivation was positively shifted and incomplete, thus widening the voltage 'window' over which sustained I CaL was present ( Table 1) . In mutant clones I CaL inactivation was also slower than in CTR1 cells; as indicated by r 100 and r 300 values (Figure 2 ), this was due to weaker CDI. The wider 'window' and slower inactivation converged to enhance I CaL sustained component in mutant hiPSC-CMs. I CaL recovery from inactivation is regulated by CaMKII 22 and relevant to I CaL rate-dependency. Recovery time-course was tested for total I CaL and after subtraction of the non-inactivating component (see Supplementary material online, Figure S5 ). As expected from defective CDI, a larger proportion of total I CaL was available at short diastolic intervals in mutant hiPSC-CMs (see Supplementary material online, Figure S5B ); when the inactivating component was analysed separately, recovery kinetics was similar between CTR1 and mutant cells (see Supplementary material on line, Figure S5C ). Recovery was faster, and the weight of the noninactivating component smaller, at -80 mV than at -50 mV.
To rule out interindividual variability as a source of CDI differences, we analysed I CaL properties in hiPSC-CMs from a second healthy control (CTR2) (see Supplementary material online, Figure S6 and Table S4 ). Albeit in CTR2 I CaL was larger and its properties were marginally different from those of CTR1, CDI and 'window' parameters were closely comparable.
CaMKII is a downstream signal mediating many effects of the Ca-CaM complex. 23 CaMKII activation was unexpectedly stronger in mutant hiPSC-CMs than in CTR1 ones (see Supplementary material online, Figure S7 ). Rate-dependent and CaMKII-mediated I CaL facilitation (CDF) can be detected in ventricular myocytes of different species. 24 However, CDF could not be induced even in CTR1 hiPSC-CMs (see Supplementary ma terial online, Figure S8A ). On the other hand, CDF was elicited by the same protocol in adult rat ventricular myocytes (see Supplementary ma terial online, Figure S8B ).
3.4 Effects on slow delayed rectifier K þ current (I Ks ) and late Na þ current (I NaL )
Given that both I Ks and I NaL are implicated in LQTS 25 and are modulated by CaM and/or CaMKII, 26, 27 we analysed whether changes in these currents could contribute to this specific type of LQTS phenotype. As shown in Figure 3A and B, I Ks I-V relationships and its steady-state activation were similar in CTR1 and mutant hiPSC-CMs. Non-inactivating components of I Na , Na þ 'window current' (I Naw ) and I NaL , were evaluated by applying slow voltage ramps ( Figure 3C and D) as previously reported. 28 TTX-sensitive current peaking at -38.0 ± 2.1 mV (CTR1, NS vs. F142L), mostly representing I Naw , was less expressed in mutant cells, while no differences between groups were observed in the current activated at 0 mV, mostly representing I NaL . Overall, in comparison to CTR1 hiPSC-CM, mutant cells showed smaller sustained I Na , a finding opposite to what required to account for QT prolongation. 
Effects on cardiac bodies and pacemaking
To reproduce tissue environment, field-potentials were recorded from spontaneously beating CBs at baseline and during b-adrenergic stimulation by isoproterenol (Iso 0.05-1.6 mM). The RR and QT intervals of CBs from the two mutant clones (c1 and c2) were similarly prolonged (P < 0.05 vs. CTR1, Figure 4A ), reproducing both the bradycardic and LQTS phenotype of the patient. The relation between QT and RR intervals, evaluated by linear fitting ( Figure 4B ), was steeper in mutant CBs than in CTR1 ones (slope 0.22 ± 0.05 vs. 0.09 ± 0.02, P < 0.05) with a similar intercept. QTc was prolonged in mutant CBs ( Figure 4B, inset) . Isoproterenol effect on QT and RR saturated already at 0.05 mM and, at this concentration, it was larger in mutant than in CTR1 CBs ( Figure 4C ). Isoproterenol significantly increased QT/RR steepness in mutant CBs ( Figure 4D , 0.49 ± 0.07, P < 0.05 vs. -Iso) while had no effect on CTR1 ones ( Figure 4D , 0.08 ± 0.04, NS vs. -Iso). Consistent with repolarization differences, contraction was more sustained and relaxation was slower in mutant CBs (see Supplementary material online, Figure S9 ).
In spite of the slow beating rate in mutant CBs, the pacemaker current (I f ) was grossly similar in CTR1 and F142L hiPSC CMs (see Supplementary material online, Figure S10 ). The I f activation curve was slightly shallower in mutant cells (k from 7.7 to 9.7 mV, P < 0.05), a finding that can unlikely account alone for the huge difference in beating rate between groups.
Effect on electrical activity in isolated hiPSC-CMs
Mutation effects on AP repolarization and its rate-dependency were evaluated in hiPSC-CMs with ventricular-like APs (observed in > 80% of cells). The effect of DC on AP parameters is shown in Supplementary material online, Figure S11 . Cells were studied under native conditions (see Supplementary material online, Figure S12 ) and during I K1 injection via DC ( Figure 5 ). I K1 injection resulted in 'mature', ventricular-like AP contours, reduced AP duration (APD) variability and highlighted mutation-induced differences. Under DC, mutant hiPSC-CMs had significantly longer APD compared to CTR1 at all pacing rates below 3.3 Hz (Figure 5A and B) . Whereas injected I K1 density during diastole was similar between control and mutant hiPSC-CMs, peak I K1 during the late AP repolarization phase was smaller in mutant ones, particularly at low pacing rate (see Supplementary material online, Figure S13 ), probably as a consequence of shallower AP repolarization in these cells 29 (see Supplementary material online). In 20% of mutant cells, stimulation at 2 Hz induced APD alternans, which was never observed in CTR1 ones. At 3.3 Hz, 10% of CTR1 cells and 50% of mutant ones (P < 0.05, Figure 5C and D) could not follow stimulation because of failure of APD to shorten adequately. Numerical simulations showed that, at variance with the normal model, in the mutant one APD failed to adapt to 3.3 Hz pacing rate (mF142L trace in Figure 5E ). Notably, the defect in I CaL CDI was alone sufficient to account for the abnormality (mF142L CDIonly trace in Figure 5E ). After Figure S12) ; however, mutation-induced differences were less pronounced and partially obscured by intercellular variability.
Effect on intracellular Ca 2þ handling
CaM participates in the regulation of intracellular Ca 2þ dynamics 8 which, in turn, may affect electrical stability. 30 CaT amplitude was larger in mutant hiPSC-CMs than in CTR1 cells, however, because Ca 2þ influx through I CaL was also increased, the excitation-release (ER)-gain was unchanged ( Figure 6A-B) . In spite of the large difference in sarcolemmal Ca 2þ influx, SR Ca 2þ content was not affected by the mutation (Figure 6C-E) . The kinetics of Ca 2þ decay during the caffeine pulse (s decay 1.88 ± 0.26 s vs. 1.93 ± 0.35 s, NS) and NCX 'conductance', were also similar between mutant and CTR1 cells ( Figure 6E ).
Pharmacological induction and rescue of the LQT phenotype
Failure of I CaL CDI was pharmacologically induced by buffering subsarcolemmal Ca 2þ . CTR1 and F142L hiPSC-CMs were incubated with the membrane permeable Ca 2þ chelator BAPTA-AM (5 mM) for about 45 min. As shown in Figure 7A , at low pacing rates the repolarization was dramatically prolonged and unstable in both cell types; early after depolarizations (EADs) occurred and APD adaptation failed in most of cells at 2 Hz. Overall, removal of CDI by Ca 2þ chelation abolished differences between CTR and mutant cells. Rescue of LQTS phenotype was then tested by analysing the sensitivity of repolarization to verapamil and amlodipine in CBs by MEA recordings. Verapamil 50 nM shortened QTc significantly in mutant CBs, but had no effect on CTR1 ones ( Figure 7B) . Also amlodipine shortened QTc in mutant CBs (see Supplementary material online, Figure S14 ), but only at > _900 nM, i.e. well above the EC 50 for inhibition of contraction (10 nM). 31 
Discussion
The present work provides functional characterization of F142L-CaM in hiPSC-CMs derived from a symptomatic mutation carrier. The experimental strategy allowed to identify derangements, and relate them to clinical manifestations, in the context of native allelic balance and in the presence of all the factors, which might affect mutation expressivity. The mutation affected I CaL time-course in a way consistent with delayed repolarization, the hallmark of the syndrome. I Ks was unaffected and sustained I Na was even smaller in mutant cells. Handling of intracellular Ca 2þ was not directly altered, thus suggesting that the arrhythmogenic potential of this mutation may primarily reside in the electrophysiological abnormality. Even in the presence of the native allelic balance, F142L-CaM caused marked CDI abnormality to imply strong negative dominance of the mutant protein. (Figure 6 ), the mutation did not cause RyRs instability, which would be expected from loss of modulation by CaM. 8 The latter would also be expected to reduce CaMKII activity, which was nevertheless increased in mutant hiPSC-CMs. 10 On the other hand, CDI was strongly impaired by a mutation affecting only 1 8, 22 and destabilize Na v 1.5 channel inactivation (I NaL enhancement). 27 RyR facilitation, if present, was not large enough to be functionally relevant. I CaL facilitation (CDF) was absent even in control hiPSC-CMs (see Supplementary material online, Figure S8 ). The present data provide the first comparative measurement of I CaL CDF in human and rodent cells; nevertheless, the absence of the phenomenon in the former might also reflect hiPSC-CMs immaturity (e.g. lack of T-tubules). 36 Therefore, the present observation should not be considered conclusive for the absence of I CaL facilitation in mature human cardiomyocytes. Moreover, I NaL was unaffected and I Naw was even decreased in mutant hiPSC-CMs; thus, changes in these currents are unlikely to contribute to mutation-induced QT prolongation. CaMKII activity was found to be enhanced in F142L hiPSC-CMs, but still inadequate to induce the expected functional changes (RyR and I CaL facilitation, I NaL enhancement).
Target specificity and negative dominance
Defective CDI and prolonged repolarization might increase SR Ca 2þ content, which was instead unaffected by the mutation ( Figure 6E ).
While this might reflect adaptive upregulation of Ca 2þ efflux, NCX 'conductance' was unchanged ( Figure 6D and E) and, at least at transcriptional level, other Ca 2þ transports were also unmodified ( Figure 1) . Therefore, we propose that, under the present conditions, the functional reserve of existing NCX, recruited by the larger Ca 2þ transients, was adequate to balance the extra Ca 2þ influx. This interpretation is consistent with previous work
showing that Ca SR is largely independent of sarcolemmal Ca 2þ influx. 37 
Reproduction of clinical phenotype and pro-arrhythmic mechanism
The mutation carrier had prolonged QTc and a markedly non-linear QT/RR relationship, reflecting enhanced QT rate-dependency during tachycardia which, in turn, likely mirrors sympathetic activation. All these features were also present in mutant CBs (and hiPSC-CMs), in which QTc was prolonged, QT/RR (and APD/CL) relation was steeper and abnormally sensitive to isoproterenol. T wave alternans also occurred in the patient, possibly matching the higher incidence of repolarization irregularities in mutant hiPSC-CMs. As most LQTS patients, the proband was bradycardic and this was reproduced in vitro by measuring spontaneous rate in CBs. Pacemaking can originate from pacemaker current (I f ) and/or from an intracellular Ca 2þ clock. 38 ; therefore, failure of Ca SR to increase significantly is not surprising. Nevertheless, Ca SR was measured here under V-clamp, a condition not representative of invivo electrical activity; we cannot rule out that prolonged repolarization might change the Ca 2þ influx/efflux balance at short cycle lengths.
Limpitikul et al. 12 found CALM-F142L overexpression to increase Ca SR in guinea-pig myocytes even at very low pacing rates (0.1 Hz) and suggested instead that SR instability might contribute to arrhythmogenesis. Notably, these experiments were performed at room temperature, at which myocytes were incompletely polarized and had extremely slow repolarization; such conditions are clearly inadequate to provide information on Ca 2þ influx/efflux balance in vivo. On the other hand, Yin et al. 11 reported unchanged Ca SR at 1 Hz in foetal murine myocytes.
Whether or not the mutation may result in intracellular Ca 2þ overload, the complete absence of afterpotentials in I-clamp recordings (even at high pacing rates), argues against SR instability as a mechanism contributing to arrhythmogenesis. Repolarization was affected by two apparently antithetical abnormalities. In a large fraction of mutant isolated hiPSC-CMs, APD failed to shorten at high rates (3.3 Hz, Figure 5D ), likely because of abnormal persistence of I CaL availability (see Supplementary material online, Figure S5 ); this caused failure, or major distortion of subsequent excitations ( Figure 5C ). This defect was not observed in mutant CBs (Figure 4) , possibly because delayed repolarization limited spontaneous beating rate. The second abnormality consisted of steeper QT/ RR and APD/CL relations (Figures 4 and 5) . Strong rate-dependency of repolarization is known to entail proarrhythmic risk. 39 APD prolongation on its own causes steeper APD rate-dependency, 29 but defective CDI might contribute to enhance sensitivity to b-adrenergic stimulation.
Simulation results confirmed that failure of APD adaptation to high pacing rates occurs in the presence of defective CDI of I CaL . Separation of the CDI defect from the other abnormalities detected in F142L hiPSC-CMs suggest that the former alone is adequate to account for the phenotype ( Figure 5E ).
Analysis of CALM1-F142L mutation in hiPSC-CMs
Clinical implications
The present results suggest that, in the case of CALM1-F142L, arrhythmogenesis may strictly result from the effect of excess I CaL on repolarization. If this is the case, I CaL blockade may be a logical therapeutic approach. The observation that verapamil reversed the mutation phenotype is consistent with this view. Thus, the identification of the arrhythmogenic mechanisms in the context of patient's genotype may enable the development of tailored therapeutic strategies.
Previous studies found QT-prolonging CaM mutations (e.g. D130G) to impair the ability of foetal murine cells to follow pacing even at slow rates. 11 This potentially arrhythmogenic feature was reversed by b-adrenergic stimulation, which was thus suggested as a therapeutic approach. 11 However, this abnormality was rare in the case of F142L-CaM 11 and, also in the present study, occurred at high rates only. On the other hand, enhanced sensitivity of repolarization to b-adrenergic stimulation might entail proarrhythmic risk. 39 Therefore, the present data do not support the view that b-adrenergic stimulation may represent a therapeutic approach, at least in the case of F142L-CaM.
Study limitations
A limitation in modelling arrhythmogenic syndromes with hiPSC-CM is represented by the degree of maturity of these cells, which often are more similar to foetal rather than adult CMs. Low I K1 expression is an important aspect of electrical immaturity, which we compensated by I K1 injection (DC technique). Other aspects of immaturity could not be corrected; consequently, extrapolation of our results should be done with caution. Isogenic control hiPSC-CMs were not available for this study. To provide a comparison adequate to identify mutation-induced abnormalities, the opposite strategy of using multiple controls with maximal genetic heterogeneity was adopted. To this end, two iPSC-CMs control lines were generated from healthy donors with different gender and ethnicity, factors known to be involved in setting channels expression and AP duration. Except for different peak I CaL magnitude, a complete consistency between CTR cell lines was found in I CaL properties relevant to repolarization course, such as window current and CDI. This sharply contrasts with the obvious abnormality in the persistent I CaL component observed in F142L hiPSC-CMs.
Generalization of the mechanisms identified in the present study to all cases of the F142L CaM mutation is limited by the fact that all mutant cell lines originated from a single mutation carrier.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
